Public HealthEuropean Commission In the spotlight À la uneNews announcement16 janvier 2026Enhancing collaboration for health security1 min de lectureNews announcement7 janvier 2026Health Technology Assessment: New opportunity to apply for Joint Scientific Consultations1 min de lectureNews announcement7 janvier 2026Register now: Safe Hearts Plan - stakeholder webinar1 min de lectureNews announcement18 décembre 2025Commission designates new EU reference laboratories for high-risk in vitro diagnostic medical devices1 min de lectureVoir les dernières mises à jour du site Health topics EU action on health BiotechnologyOne HealthHealth Emergency Preparedness and Response (HERA)EU Health PolicyState of Health in the EUFundingInternational cooperationIndicators and data Diseases and health threats Health security and infectious diseasesVaccinationAntimicrobial resistanceNon-communicable diseases CancerMental health Improving health systems Cross-border healthcareRare diseases and European Reference NetworkseHealth : Digital health and careHealth technology assessmentHealth workforceHealth systems performance assessmentExpert Panel on Effective ways of Investing in Health Risk assessment Scientific committees Pharmaceuticals Medicinal productsEudraLexUnion RegisterPharmaceutical committee and expert groups Substances of human origin Blood, tissues, cells and organs Medical devices SectorNew regulationsIn Vitro DiagnosticsTopics of InterestDialogue between interested partiesExpert PanelsEUDAMEDClinical investigations and performance studies Endocrine disruptors Endocrine disruptors Biocides Biocides Promoting good health TobaccoNutrition and physical activityAlcoholSocial determinants Priorités politiquesPharmaceuticalsOne HealthUnion européenne de la santé
News announcement7 janvier 2026Health Technology Assessment: New opportunity to apply for Joint Scientific Consultations1 min de lecture
News announcement18 décembre 2025Commission designates new EU reference laboratories for high-risk in vitro diagnostic medical devices1 min de lecture
